Safety and Efficacy of BAF312 in Dermatomyositis
Clinical trial NCT02029274 · TERMINATED
Trial details
- NCT number
- NCT02029274
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-25
- Primary completion
- 2016-02-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.